Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey

BACKGROUND AND AIM: Limited data are available in clinical settings on the pharmacokinetics of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). We investigated the use of cannabis-based products in neurological practice, monitoring patients' steady-state cannabinoids (CBs) plasma conce...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Susan, Lopane, Giovanna, Sabattini, Loredana, Scandellari, Cinzia, Zardi, Diletta, Donadio, Vincenzo, Rizzo, Giovanni, Perrone, Alessandro, Lugaresi, Alessandra, Contin, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997238/
https://www.ncbi.nlm.nih.gov/pubmed/35418935
http://dx.doi.org/10.3389/fneur.2022.784748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997238/
https://www.ncbi.nlm.nih.gov/pubmed/35418935
http://dx.doi.org/10.3389/fneur.2022.784748

Ejemplares similares